Comment on "Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration"

被引：0
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med, Dept Ophthalmol, Cluj Napoca 400012, Romania
来源：
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY | 2018年 / 11卷 / 11期
关键词：
POLYPOIDAL CHOROIDAL VASCULOPATHY; AFLIBERCEPT TREATMENT; CLASSIFICATION;
D O I：
10.18240/ijo.2018.11.25
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1884 / 1885
页数：2
相关论文
共 50 条
  • [21] Long-term experience with lucentis (ranibizumab) in patients with neovascular age-related macular degeneration (AMD)
    Heier, JS
    Rosenfeld, PJ
    Antoszyk, AN
    Hantsbarger, G
    Kim, R
    Shams, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [22] Long-term longitudinal study of patients treated with ranibizumab for neovascular age-related macular degeneration
    Rasmussen, Annette
    Sander, Birgit
    CURRENT OPINION IN OPHTHALMOLOGY, 2014, 25 (03) : 158 - 163
  • [23] Long-term anatomical and functional outcomes in patients with neovascular age-related macular degeneration (nAMD) after switching from Ranibizumab to Aflibercept therapy
    Christou, Louise
    Kirthi, Varo
    Peregrine, Helen
    Essaji, Fariha
    Canning, Sarah
    Ioannidis, Pantelis
    Kashani, Shahram
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [24] Long term visual outcomes in ranibizumab non-responders: patients with neovascular age-related macular degeneration switched from ranibizumab to aflibercept
    Afshar, Farid
    Fletcher, Emily
    Mohamed, Quresh
    Johnston, Rob
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [25] Long-term anatomical and functional outcomes after switch to aflibercept therapy for neovascular age-related macular degeneration
    Chae, Bora
    Barbazetto, Irene
    Gallego-Pinazo, Roberto
    Patel, Samir
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [26] Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Jin, Ki Won
    Kim, Jae Hui
    Park, Jun Young
    Park, Sang Jun
    Park, Kyu Hyung
    Lee, Joo Yong
    Woo, Se Joon
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] Long-Term Outcomes Of Intravitreal Ranibizumab In Patients With Neovascular Age-Related Macular Degeneration. Besides Clinical Trials
    Juan Escobar, Jose
    Gallego, Roberto
    Romero, Beatriz
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [28] Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Ki Won Jin
    Jae Hui Kim
    Jun Young Park
    Sang Jun Park
    Kyu Hyung Park
    Joo Yong Lee
    Se Joon Woo
    Scientific Reports, 11
  • [29] Assessment of the effectiveness and safety of ranibizumab in neovascular age-related macular degeneration
    Real Campana, Jose Manuel
    Carrera Lafuentes, Patricia
    Torron Fernandez-Blanco, Clemencia
    Huarte Lacunza, Rafael
    Varela Martinez, Isabel
    Rabanaque Hernandez, M. Jose
    MEDICINA CLINICA, 2011, 136 (11): : 471 - 477
  • [30] Long-Term Intraocular Pressure Changes in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab
    Menke, Marcel N.
    Salam, Adzura
    Framme, Carsten
    Wolf, Sebastian
    OPHTHALMOLOGICA, 2013, 229 (03) : 168 - 172
12345